论文部分内容阅读
尽管与云南红塔之间关于云南白药股权纠纷历时五年仍败诉,但新华都和公司董事长陈发树却通过二级市场大量购入股票,从而出现在云南白药股东前十榜上。昨日晚间,云南白药发布的2015年半年报显示,新华都在上半年买入2 706万股,持股比例达到2.75%,成为云南白药第四大股东,新华都董事长陈发树买入382.7万股,持股比例达0.59%,跻身云南白药第七大股东。
Despite a five-year dispute over the Yunnan Baiyao stake dispute with Yunnan Hongta, the new Huadu and Chen Fa-shu, chairman of the company, purchased a large amount of shares through the secondary market, resulting in the top ten list of Yunnan Baiyao shareholders. Yesterday evening, Yunnan Baibu released 2015 semi-annual report shows that Xinhua bought 26.6 million shares in the first half, holding 2.75% stake, becoming the fourth largest shareholder of Yunnanbaiyao, Chen Huashu, chairman of Xinhua Buy 3.827 million shares , Holding a ratio of 0.59%, among the seventh largest shareholder of Yunnanbaiyao.